Published in CMAJ on June 01, 1992
The economic burden of physical inactivity in Canada. CMAJ (2000) 3.51
Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. CMAJ (2000) 2.12
Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status. CMAJ (2000) 1.74
When should hypertension be treated? The different perspectives of Canadian family physicians and patients. CMAJ (2000) 1.51
The impact of cardiovascular risk-factor profiles on blood pressure control rates in adults from Canada and the United States. Can J Cardiol (2013) 1.50
The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ (2001) 1.44
The Air Quality Health Index as a predictor of emergency department visits for ischemic stroke in Edmonton, Canada. J Expo Sci Environ Epidemiol (2013) 0.90
Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. CMAJ (1999) 0.86
Cardiovascular disease risk factors and socioeconomic variables in a nation undergoing epidemiologic transition. BMC Public Health (2013) 0.83
Cardiovascular disease: risk factors in older Canadians. CMAJ (1999) 0.79
Factors affecting use of preventive tests for cardiovascular risk among Greeks. Int J Environ Res Public Health (2009) 0.78
Family history and the risk of coronary heart disease: comparing predictive models. Eur J Epidemiol (2001) 0.78
Immediate effects of upper thoracic spine manipulation on hypertensive individuals. J Man Manip Ther (2015) 0.75
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Cardiovascular disease risk profiles. Am Heart J (1991) 21.65
Probability of stroke: a risk profile from the Framingham Study. Stroke (1991) 10.14
Effects of communitywide education on cardiovascular disease risk factors. The Stanford Five-City Project. JAMA (1990) 7.44
Community education for cardiovascular health. Lancet (1977) 6.32
A prospective study of obesity and risk of coronary heart disease in women. N Engl J Med (1990) 6.06
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Risk factors for ischaemic heart disease: the prospective phase of the British Regional Heart Study. J Epidemiol Community Health (1985) 5.53
Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) (1984) 5.06
Social/economic status and disease. Annu Rev Public Health (1987) 5.03
Social class differences in ischaemic heart disease in British men. Lancet (1987) 4.09
Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. N Engl J Med (1990) 3.99
The decline in ischemic heart disease mortality rates. An analysis of the comparative effects of medical interventions and changes in lifestyle. Ann Intern Med (1984) 3.71
The value of lowering cholesterol after myocardial infarction. N Engl J Med (1990) 3.10
Coronary risk factors and socioeconomic status. The Oslo study. Lancet (1976) 2.67
Relationship of education to major risk factors and death from coronary heart disease, cardiovascular diseases and all causes, Findings of three Chicago epidemiologic studies. Circulation (1982) 2.65
The relationship of education to blood pressure: findings on 40,000 employed Chicagoans. Circulation (1976) 2.64
A comparison of trends of coronary heart disease mortality in Australia, USA and England and Wales with reference to three major risk factors-hypertension, cigarette smoking and diet. Int J Epidemiol (1980) 2.51
Risk factors for coronary heart disease and level of education. The Tromsø Heart Study. Am J Epidemiol (1988) 2.47
The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med (1991) 2.42
Socioeconomic disparities in risk factors for cardiovascular disease. CMAJ (1986) 2.33
Decline in cardiovascular mortality in North Karelia and other parts of Finland. Br Med J (Clin Res Ed) (1986) 2.22
What can be done about inequalities in health? Lancet (1991) 2.21
Socioeconomic differentials in cancer among men. Int J Epidemiol (1991) 2.13
Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol (1985) 1.84
A review of five major community-based cardiovascular disease prevention programs. Part II: Intervention strategies, evaluation methods, and results. Am J Health Promot (1990) 1.83
Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study. Ann Intern Med (1991) 1.69
Population risk of cardiovascular disease: the Minnesota Heart Survey. J Chronic Dis (1985) 1.65
The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J (1988) 1.38
Clustering of cardiovascular disease risk factors. Prev Med (1980) 1.29
Stratifying the patient at risk from coronary disease: new insights from the Framingham Heart Study. Am Heart J (1990) 1.24
The ratio of waist-to-hip circumference, plasma insulin level, and glucose intolerance as independent predictors of the HDL2 cholesterol level in older adults. N Engl J Med (1990) 1.14
Level of education, coronary risk factors and cardiovascular disease. Ir Med J (1984) 0.92
Synergistic effects of risk factors. Clin Exp Hypertens A (1990) 0.89
Is cardiovascular risk factor knowledge sufficient to influence behavior? Am J Prev Med (1990) 0.87
Prevalence, control and awareness of high blood pressure among Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 2.98
Distribution of blood pressure and hypertension in Canada and the United States. Am J Hypertens (2001) 2.96
Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Breast Cancer Screening. Int J Epidemiol (1998) 2.49
Tobacco use, occupation, coffee, various nutrients, and bladder cancer. J Natl Cancer Inst (1980) 2.44
A comparative evaluation of waist circumference, waist-to-hip ratio and body mass index as indicators of cardiovascular risk factors. The Canadian Heart Health Surveys. Int J Obes Relat Metab Disord (2001) 2.03
Rationale for and outline of the recommendations of the Working Group on Hypercholesterolemia and Other Dyslipidemias: interim report. Dyslipidemia Working Group of Health Canada. Can J Cardiol (1998) 1.88
Oesophageal, rectal, axillary, tympanic and pulmonary artery temperatures during cardiac surgery. Can J Anaesth (1998) 1.79
Self-management teaching programs and morbidity of pediatric asthma: a meta-analysis. J Allergy Clin Immunol (1995) 1.74
Plasma lipids and lipoproteins and the prevalence of risk for coronary heart disease in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.54
Congenital heart disease: incidence in the first year of life. The Alberta Heritage Pediatric Cardiology Program. Am J Epidemiol (1988) 1.54
Cervical cancer screening: are the 1989 recommendations still valid? National Workshop on Screening for Cancer of the Cervix. CMAJ (1996) 1.49
Drinking water hardness and urolithiasis. Ann Intern Med (1978) 1.45
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
The 2000 Canadian recommendations for the management of hypertension: Part one--therapy. Can J Cardiol (2001) 1.42
Artificial sweeteners and human bladder cancer. Lancet (1977) 1.40
Comparison of esophageal, rectal, axillary, bladder, tympanic, and pulmonary artery temperatures in children. J Pediatr (1998) 1.38
Evaluation of alternative calculation methods for determining LDL cholesterol. Vnitr Lek (2008) 1.38
Enhancing global capacity in the surveillance, prevention, and control of chronic diseases: seven themes to consider and build upon. J Epidemiol Community Health (2008) 1.31
Relationship of magnesium intake and other dietary factors to blood pressure: the Honolulu heart study. Am J Clin Nutr (1987) 1.30
Consensus reports: implications for the management of hypercholesterolemia and for future research. CMAJ (1989) 1.29
Prepupal larval mosaics in Drosophila melanogaster. Nature (1976) 1.25
Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease. CMAJ (1999) 1.24
Smoking and caffeine and alcohol intake during pregnancy in a northern population: effect on fetal growth. CMAJ (1992) 1.15
Ketone aldehydes in animal tissues. Proc Natl Acad Sci U S A (1967) 1.14
A minimal prevalence study of diagnosed diabetes in Newfoundland and Labrador. Can J Public Health (1991) 1.13
Success of a program of routine prenatal screening for hepatitis B surface antigen: the first 2 years. CMAJ (1990) 1.13
Managing hypercholesterolemia. CMAJ (1989) 1.13
Common variable immunodeficiency, Hodgkin's disease, and other malignancies in a Newfoundland family. Lancet (1975) 1.12
[Epidemiological profile of thyroid volume and disorders in Slovakia]. Vnitr Lek (2000) 1.10
Prevalence of sexually transmitted diseases in juvenile prostitutes and street youth. Can J Infect Dis (1994) 1.09
Increased thyroid volume and prevalence of thyroid disorders in an area heavily polluted by polychlorinated biphenyls. Eur J Endocrinol (1998) 1.08
Idiopathic hypertrophic subvalvular stenosis. A study of a family involving four generations. Clinical, hemodynamic and pathologic observations. Am J Cardiol (1966) 1.04
Body mass index versus waist circumference as predictors of mortality in Canadian adults. Int J Obes (Lond) (2012) 1.02
A dissemination research agenda to strengthen health promotion and disease prevention. Can J Public Health (1997) 1.02
Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J (1992) 1.01
Sociodemographic variation in the prevalence of cardiovascular disease. Can J Cardiol (1996) 0.99
Nutrition education practices and opinions of alberta family physicians. Can Fam Physician (1990) 0.95
Technique for determining the bactericidal effect of drug combinations. Antimicrob Agents Chemother (1974) 0.93
A cardiovascular risk factor reduction clinic. Can J Cardiol (1999) 0.91
Adherence to management of high blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Can J Public Health (1999) 0.90
Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man. Metabolism (1971) 0.88
Prevalence of cerebral palsy in Alberta. Can J Neurol Sci (1998) 0.86
Prevalence of risk factors for cardiovascular disease in Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. CMAJ (1999) 0.86
Venous thromboembolism in association with features of the metabolic syndrome. QJM (2007) 0.86
Effect of chlorophenoxyisobutyrate on the metabolism of endogenous glycerides in man. Metabolism (1971) 0.86
A case of mitral insufficiency following myocardial infarction with rupture of a papillary muscle: improvement following reattachment of the papillary muscle and plication of the mitral valve. Can Med Assoc J (1966) 0.86
Chlamydia trachomatis genital infection. Can Fam Physician (1997) 0.86
The effects of education and group discussion in the post myocardial infarction patient. J Psychosom Res (1984) 0.85
Urolithiasis--a study of drinking water hardness and genetic factors. J Chronic Dis (1980) 0.84
Mechanisms of action of cholestyramine in the treatment of hypercholesterolemia. Circulation (1972) 0.83
Selective screening for dyslipidemia in a Canadian population. J Clin Epidemiol (1996) 0.83
Evaluation of the echocardiogram as an epidemiologic tool in an asymptomatic population. Circulation (1979) 0.83
Intradermal testing for food and chemical sensitivities: a double-blind controlled study. J Allergy Clin Immunol (1999) 0.83
Prevalence of cardiovascular risk factors in Canadians with diabetes mellitus. Adv Exp Med Biol (2001) 0.82
Perception of uncontrolled blood pressure and behaviours to improve blood pressure: findings from the 2009 Survey on Living with Chronic Diseases in Canada. J Hum Hypertens (2011) 0.81
An intersectoral network for chronic disease prevention: the case of the Alberta healthy living network. Chronic Dis Can (2009) 0.81
Toward the development of self-help health behaviour change programs: weight loss by correspondence. Can J Public Health (1990) 0.80
Three years' experience with implanted pacemakers. Can Med Assoc J (1967) 0.80
Mechanisms of hypolipidemic action of nicotinic acid. Clin Pharmacol Ther (1978) 0.79
Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man. Circulation (1971) 0.79
The search for new cancerostatic agents. Ciba Found Symp (1978) 0.79
How to deal with medically unknown symptoms. West J Med (2000) 0.79
A survey of physicians' uses/opinions regarding nutrition education resources. J Can Diet Assoc (1990) 0.79
Static and dynamic pupillometry for determination of the course of gradual detoxification of opiate-addicted patients. Eur Arch Psychiatry Clin Neurosci (1990) 0.79
The prevalence of hyperlipidemia in women and its association with use of oral contraceptives, sex hormone replacement therapy and nonlipid coronary artery disease risk factors. Canadian Heart Health Surveys Research Group. Can J Cardiol (1999) 0.78
Isolation of methylglyoxal from liver. Proc Natl Acad Sci U S A (1978) 0.78
Infant feeding practices in Ottawa-Carleton: the introduction of solid foods. Can J Public Health (2000) 0.78
Absorption of dietary cholesterol in man. Metabolism (1973) 0.78
A new class of synthetic biological response modifiers: the methylfurylbutyrolactones (Nafocare B). J Biol Response Mod (1986) 0.77
A simple method for calculating absorption of dietary cholesterol in man. Proc Soc Exp Biol Med (1971) 0.77
Comparative trial of doxazosin and atenolol on cardiovascular risk reduction in systemic hypertension. The Alpha Beta Canada Trial Group. Am J Cardiol (1993) 0.77
Effect of methoxy-p-benzoquinones and methoxy-p-hydroquinones on DNA synthesis in Ehrlich ascites tumor cells. Acta Biochim Biophys Hung (1987) 0.77
Thyroid volume, iodine intake, autoimmune thyroid disorders, inborn factors, and endocrine disruptors: twenty-year studies of multiple effects puzzle in Slovakia. Endocr Regul (2012) 0.76
Effect of a new inhibitor of cholesterol biosynthesis (AY 9944) on serum and tissue sterols in the rat. J Lipid Res (1966) 0.76
[Ultrasonography of the neonatal hip: state of the art and perspectives]. Radiol Med (1996) 0.75
Geology and disease in Newfoundland. Can Med Assoc J (1973) 0.75
An unusual case of abdominal arteriovenous fistula. Tex Heart Inst J (1985) 0.75
The Master Two-Step Test. Can Med Assoc J (1959) 0.75
[Not Available]. Can Fam Physician (1983) 0.75
[The beginning stages of Cushing's syndrome]. Vnitr Lek (1984) 0.75
Novel method of configurational correlation: (+)-sedridine and S-(+)-octan-2-ol. Chem Ind (1968) 0.75
[General anesthesia in temporomandibular ankylosis]. Stomatologia (Bucur) (1970) 0.75
On the hepato-protective effect of selenium in carbon tetrachloride poisoning in albino rats. Experientia (1965) 0.75
[General anesthesia in children with labio-maxillo-palatine clefts]. Stomatologia (Bucur) (1970) 0.75
Tropane alkaloids. Nat Prod Rep (1985) 0.75
On the protective action (anticirrhogenic) of inorganic selenium in hepatic lesions of alimentary origin. Rom Med Rev (1967) 0.75
Physician management of hyperlipidemia in Saskatchewan: temporal trends and the effect of a CME program. Can J Cardiol (1991) 0.75
[Optical rotation and conformation. VI. N.M.R. spectra and conformation of some stereoisomeric 2.3-disubstituted morpholines and 5-oxomorpholines]. Chem Ber (1972) 0.75
[Palliative treatment units: a new approach to patients in the terminal phase]. Union Med Can (1982) 0.75
[Intraventricular conduction disorders in hypertension]. Orv Hetil (1978) 0.75
Prevention of fatal and nonfatal ischemic heart disease by early treatment of hypertension. Cardiology (1985) 0.75
[Reduction of bleeding by vasoconstrictive drugs infiltration in the surgery cleft lip and cleft palate]. Stomatologia (Bucur) (1972) 0.75
Relaxation therapy for essential hypertension: a Veterans Administration Outpatient study. J Behav Med (1979) 0.75
Tropane alkaloids. Nat Prod Rep (1986) 0.75
[The use of epsilon-amino-caproic acid (EACA) for hemostasis in selective dental extractions in hemophiliacs]. Stomatologia (Bucur) (1971) 0.75
Prevention programs in Canada. Adv Exp Med Biol (1977) 0.75
Tropane alkaloids. Nat Prod Rep (1984) 0.75
Multi-channel commutator for recording biopotentials from small animals. Physiol Behav (1978) 0.75